Dare Bioscience
DARE
$0.41
Share price
-4.78%
Change (1 day)
-59.41%
Change (1 year)
Categories
Dare Bioscience (DARE) - P/B ratio
P/B ratio as of June 2024 : -4.32
According to Dare Bioscience
's latest financial reports the company has a price-to-book ratio of -4.32.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Dare Bioscience - P/B ratio (from 2014 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -6.03 | -195.23% |
| 2022-12-31 | 6.34 | 60.27% |
| 2021-12-31 | 3.95 | -108.94% |
| 2020-12-31 | -44.2 | -220.72% |
| 2019-12-31 | 36.6 | 2934.81% |
| 2018-12-31 | 1.21 | 22.55% |
| 2017-12-31 | 0.9844 | -103.6% |
| 2016-12-31 | -27.3 | -1840.53% |
| 2015-12-31 | 1.57 | -43.12% |
| 2014-12-31 | 2.76 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.83 | -142.41% | 🇺🇸 USA |